-
Posted by
Two Blokes Jun 6 -
Filed in
Stock
-
9 views
Dexterra retains a buy rating after strong revenue growth, improved margins, and successful integration of the CMI acquisition. Q1 results showed 3.4% revenue growth, a swing to net earnings, and a 29% increase in adjusted EBITDA, driven by high camp occupancy. Management's proactive contract adjustments and inflation-aligned rate increases support profitability and resilience in uncertain environments.
